Achira
Atomistic foundation simulation models for drug discovery and other physical-science applications
Highlights
- New on EvolcAdded 2026-11-14
About Achira
Achira develops atomistic world models that combine machine learning, physics, quantum chemistry and statistical mechanics to model how atoms and forces behave. Its foundation simulation models are intended to support drug discovery and other applications in physical sciences.
The company invites drug discovery scientists to partner with it to access its models. It is recruiting machine learning researchers and engineers, software engineers, applications scientists and people operations staff.
Achira lists offices in San Francisco and New York. Its investors include Dimension, Amplify Partners, NVIDIA NVentures and Compound.
Product: Atomistic foundation simulation models for drug discovery and physical-science applications.
Jobs at Achira
Open roles at Achira in the Americas (4)
United States 4. From Achira's careers page or applicant tracking system; each role links to the employer.
- People Operations Manager · San Francisco, United States
- ML Research Scientist (MLRS) - Representation Learning for Molecular AI · San Francisco, United States
- ML Research Scientist (MLRS) - Generative AI · San Francisco, United States
- Machine Learning Research Engineer (MLRE) - Research · San Francisco, United States
More biotech & pharma companies
Adaptive Biotechnologies
Immune-receptor sequencing and data products for clinicians and biopharmaceutical companies developing and testing therapiesNew on EvolcAditum Bio
Biotech venture and operating firm that forms companies to develop drug candidates into medicines for patientsNew on EvolcAgcbio
Contract development and manufacturing services for biopharmaceutical companies developing biologics and advanced therapiesNew on EvolcAION Biosciences
Bioelectricity tools and medical devices for individuals seeking greater control over their biologyNew on EvolcAlltrna
Engineered tRNA medicines for patients with genetic diseases caused by disrupted protein productionNew on EvolcAllucent
Clinical research, drug development and regulatory services for small and mid-sized biotech and biopharma companiesRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- FastlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-served-by
- Response headerx-served-by
- Response headerx-served-by
Hosting
- GitHub PagesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Recruiting
- AshbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
